Artiva Biotherapeutics, Inc.
ARTV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $70 | $37 | $73 | $246 |
| - Cash | $26 | $28 | $30 | $40 |
| + Debt | $12 | $13 | $14 | $14 |
| Enterprise Value | $56 | $22 | $57 | $220 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$21 | -$22 | -$22 | -$18 |
| % Margin | – | – | – | – |
| Net Income | -$22 | -$21 | -$20 | -$9 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.88 | -0.87 | -0.83 | -0.82 |
| % Growth | -1.1% | -4.8% | -1.2% | – |
| Operating Cash Flow | -$19 | -$23 | -$20 | -$15 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$0 |
| Free Cash Flow | -$20 | -$24 | -$20 | -$15 |